☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Type-1 Diabetes
AstraZeneca's Forxiga (dapagliflozin) Receives MHLW's Approval for Type-1 Diabetes (T1D) in Japan
March 27, 2019
AstraZeneca's Forxiga (dapagliflozin) Receives EU's Approval for Type-1 Diabetes (T1D) in Adults
March 25, 2019
Load more...
Back to Home